| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,782 | 27,602 | 29,411 | 28,925 | | Cost of Revenue | 11,814 | 11,086 | 11,016 | 10,908 | | | Gross Profit | 19,968 | 16,516 | 18,395 | 18,017 | | | Operating Expenses | | Research Development | 8,730 | 8,535 | 8,635 | 8,631 | | Selling General and Administrative | 8,460 | 5,605 | 7,619 | 7,137 | | Non Recurring | 156 |
-
| (7) | 767 | | Others | 62 | 69 | 69 | 183 | | | | Total Operating Expenses | 17,408 |
-
| 16,316 | 16,718 | | | | Operating Income or Loss | 2,560 | 2,307 | 2,079 | 1,299 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 264 | (340) | (427) | 1,167 | | Earnings Before Interest And Taxes | 2,824 | 1,967 | 1,652 | 2,468 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,824 | 1,967 | 1,652 | 2,468 | | Income Tax Expense | 213 | 265 | 465 | 148 | | Minority Interest | (5) |
-
|
-
| 2 | | | | Net Income From Continuing Ops | 2,606 | 1,702 | 1,187 | 2,320 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,606 | 1,702 | 1,187 | 2,320 | | Preferred Stock And Other Adjustments | 5 | (2) | (3) |
-
| | | Net Income Applicable To Common Shares | $2,611 | $1,700 | $1,184 | $2,320 |
|
0.07% Nasdaq 
0.25%
Income Statement
